David Allan Barr

Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology

Pender Growth Fund, Inc. is a diversified venture capital fund that invests in technology companies within the province of British Columbia with the objective of long-term capital appreciation. The fund focuses on expansion and restructuring opportunities within the technology sector that offer investors the potential for liquidity through either existing public listings or near term liquidity events. Pender Growth Fund was founded on March 7, 1994 and is headquartered in Vancouver, Canada.

Pender Private Equity Fund Management Inc (Pender Ventures) is a venture capital subsidiary of PenderFund Capital Management Ltd founded in 1994 by John Kelly Edmison. The firm is headquartered in Vancouver, Canada with an office in Ontario.

one45 Software, Inc. provides educational software solutions for healthcare institutions. It offers a suite of software tools for managing, scheduling, assessing, and tracking medical education programs. The company was founded by Ric Arseneau, Derek Hemmes, and John Simms in 2001 and is headquartered in Vancouver, Canada.

PenderFund Capital Management Ltd. (Pender) is an independent, value-based mutual fund firm headquartered in Vancouver, Canada. The firm was founded by J. Kelly Edmison in 2003. Pender manages a range of funds for various types of clients.